SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion

Xiaolei Liu1, Biyan Duan, Zhaokang Cheng

  • 1The Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Science, Nankai University, Tianjin 300071, China.

Protein & Cell
|November 8, 2011
PubMed

Insights

Stromal-derived factor-1 (SDF-1) enhances mesenchymal stem cell (MSC) survival and function after transplantation for acute myocardial infarction. The SDF-1/CXCR4 axis is critical for improving MSCs

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) show promise for treating acute myocardial infarction.
  • High MSC mortality post-transplantation limits therapeutic efficacy.
  • Key factors for cardiac treatment include survival, migration, and paracrine capacity.

Purpose of the Study:

  • To investigate the role of the stromal-derived factor-1 (SDF-1)/CXCR4 axis in regulating MSC survival, migration, and paracrine function.
  • To determine if SDF-1 pretreatment can enhance MSC therapeutic potential for ischemic cardiac conditions.

Main Methods:

  • Induction of apoptosis in MSCs using H2O2 exposure.
  • Pretreatment of MSCs with SDF-1.
  • Assessment of MSC survival, proliferation, migration, and cytokine secretion.
  • Analysis of signaling pathways (Akt, Erk) and protein expression (Bcl-2/Bax ratio) via Western blot and RT-PCR.
  • Inhibition studies using AMD3100, a CXCR4 antagonist.

Main Results:

  • SDF-1 pretreatment significantly increased MSC survival and proliferation post-apoptosis induction.
  • Enhanced MSC migration and increased secretion of pro-survival and angiogenic factors (bFGF, VEGF) were observed.
  • SDF-1 activated pro-survival Akt and Erk pathways and upregulated the Bcl-2/Bax ratio.
  • The CXCR4 antagonist AMD3100 partially inhibited these protective effects.

Conclusions:

  • The SDF-1/CXCR4 axis plays a critical role in promoting MSC survival, migration, and cytokine secretion.
  • SDF-1 pretreatment enhances MSC resilience and therapeutic potential for cardiac repair.
  • Targeting the SDF-1/CXCR4 pathway offers a strategy to improve stem cell therapy for myocardial infarction.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Cytoskeletal Coordination in Cell Migration01:32

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker proteins that...